Skip to search formSkip to main content

BP 1107

Known as: BP-1107, BP1107 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
BP-1107 [{2-[4-(2,4-dioxo-thiazolidin-5-ylmethyl)-phenoxy]-ethyl}-methyl-amide]: a novel synthetic thiazolidinedione that inhibits epidermal hyperplasia in psoriatic skin-severe-combined…
Recent studies have demonstrated that orally administered thiazolidinedione ligands of the peroxisome proliferator-activated… Expand
  • figure 2
  • figure 3
  • figure 5
  • figure 4
  • figure 6
Is this relevant?
2005
2005
BP-1107: A Novel, Synthetic Thiazolidinedione that inhibits epidermal hyperplasia in Psoriatic skin - SCID Mouse transplants following topical application
 
Is this relevant?
2004
2004
Rosiglitazone inhibits proliferation, motility, and matrix metalloproteinase production in keratinocytes.
This study was undertaken to evaluate the effects of thiazolidinediones (TZD) on keratinocyte proliferation, motility, and matrix… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE